By HEATHER MURPHY
NYT Health
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.
Published date: April 16, 2019 at 03:00AM
Tuesday, April 16, 2019
New Your Times - Health - Don’t Count on 23andMe to Detect Most Breast Cancer Risks, Study Warns
By HEATHER MURPHY
NYT Health
The DNA testing company, which has 10 million customers, misses nearly 90 percent of people with risky BRCA mutations. It says the criticism is overblown.
Published date: April 16, 2019 at 03:00AM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment